Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
COMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CACOMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA

Linus Peters

Peters pushed longevity as a public-legitimacy problem: if aging is treated as inevitable, talent and money stay away. That is advocacy, not proof of field impact.

34 / 100popularisercommunicator@LinusPetersScoring AI engine · v0.4.0
Role
populariserhigh confidence

The clearest longevity contribution here is field-building: he founded the Swedish Longevity Cluster and explicitly pushes longevity advocacy as necessary to change minds and mobilize resources. That is public-surface and movement infrastructure, not just commentary.

X post by LinusPetersLinus Peters X profile

also: communicator

Dimension breakdown

This score rates longevity commitment only. The role tags above — scientist, investor, and the rest — say what this person is; we don't score those separately.

Evidence is still sparse for this hero. Scores are shown with low-confidence warnings until more source material is harvested.

Future vision

7.0/ 10

Linus Petersson has clearly and repeatedly articulated an ambitious public vision that aging should be stopped, death is bad, and indefinite lifespan extension through science is a worthy goal. He also gives a social-change theory of progress: science can solve aging if society chooses to invest talent, money, and effort. The score is limited by sparse evidence, mostly self-published sources, and little detail on mechanisms, timelines, technical roadmap, or endorsed scientific theories.

medium confidence

Scientific impact

0.0/ 10

No citation metrics, authored papers, clinical trials, or independently corroborated scientific contributions are provided. The evidence shows longevity advocacy and interest in aging science, but not direct or enabled scientific impact under this result-focused dimension.

medium confidence

Capital deployed

2.0/ 10

There is limited self-published evidence that Linus Peters has directed institution-building effort toward longevity through claimed founding roles, but there is no disclosed investment, donation, fund allocation, or independently corroborated capital deployment amount. The evidence supports advocacy and organizational association more than measurable capital deployed.

low confidence

Strategic taste

4.0/ 10

Strategic taste applies, but the evidence supports mainly an advocacy and ecosystem-building thesis rather than demonstrated early, contrarian, or counterfactually important bets with clear field effects. Petersson shows a coherent high-risk thesis: aging should be treated as solvable, public legitimacy is a bottleneck, and advanced interventions are needed. Founding FundLongevity.org and the Swedish Longevity Cluster suggests some strategic deployment toward movement-building. However, the record provided lacks dates, outcomes, funding decisions, scientific program choices, or evidence that these bets opened paths others were not seeing.

low confidence

Field creation

3.0/ 10

The dimension applies because the evidence concerns advocacy and claimed organization-building, but the only direct evidence for founding activity is self-published and is contradicted by the structured facts showing no founded organizations or donation-created programs found. His posts show public longevity advocacy, which may help make the field more legible, but there is no primary or independent corroboration of creating durable organizations, programs, communities, protocols, or funding paths.

low confidence

Bravery and conviction

4.0/ 10

Evidence shows public pro-longevity conviction and some contrarian framing: Peters argues that aging should be ended and explicitly notes that indefinite lifespan extension is often treated as unserious. This supports bravery/conviction, but the record is mostly recent self-published advocacy and a TEDx talk, with no evidence of career sacrifice, major personal downside, sustained criticism, financial risk, or self-experimentation. The score is therefore modest rather than high.

medium confidence

Multiplier effect

4.0/ 10

Multiplier effect applies, but the available evidence is almost entirely self-published and shows advocacy intent more than independently verified second-order outcomes. Petersson argues for shifting public belief to attract talent, money, and effort into longevity, and his profile claims ecosystem-building roles, but there is no primary or independent corroboration of actual talent attraction, capital formation, policy influence, collaborators, founders, or follow-on projects.

low confidence
Vision

Destination

I find it frustrating that wanting to extend human lifespan indefinitely through science is still so often treated as unserious or questionable. I mean exactly what I say: life is good, and death is bad. Ending aging is a goal worth pursuing.

[S1] High 2026

Aging Can and Should be Stopped | Linus Petersson | @TEDxStockholm

[S2] High 2026

Aging Can and Should be Stopped | Linus Petersson | @TEDxStockholm

[S3] High 2026

Path

Prevention is a way to buy time for breakthrough technologies.

[S1] Medium 2026

Peters pushes us to think about diversifying our bets.

[S2] Medium 2026

Peters pushes us to think about diversifying our bets.

[S3] Medium 2026

Cryopreservation is insurance in case a biological solution arrives too late.

[S4] Medium 2026

Science can solve aging. But only if society wants it solved. If people see aging as inevitable, we won’t invest the talent, money, and effort needed to defeat it. That’s why longevity advocacy matters. Changing minds is just as important as advancing the science.

[S5] High 2026
Strategy

Longevity progress depends on shifting public demand and legitimacy so that society commits the talent, capital, and scientific effort needed to stop aging.

Petersson’s strategy centers on making aging an accepted scientific and social target rather than an inevitable condition, arguing that public belief determines whether enough talent, money, and effort flow into the field [S1]. He explicitly backs indefinite lifespan extension through science and frames death from aging as a problem worth solving, indicating a high-risk, high-upside orientation rather than incremental healthspan-only positioning [S3]. His emphasis on “advanced interventions” points toward ambitious biotechnology rather than lifestyle or prevention alone [S4]. The profile evidence supports an ecosystem-building role through FundLongevity.org and the Swedish Longevity Cluster, with a geographic anchor in Stockholm, Sweden [S8]. His reposting of AI-biology frontier coverage and positive reaction to ARPA-H regenerative neuroscience suggest interest in adjacent enabling technologies, but the evidence does not establish investments, donations, or scientific collaborations [S2][S6].

UnknownHighLongevity AdvocacyAging BiologyRegenerative NeuroscienceAI BiologyAdvanced InterventionsSwedenStockholm

Notable bets

FundLongevity.orgA founder role in a longevity-focused organization aligns with a strategy of building public and institutional support for solving aging.
Swedish Longevity ClusterFounding a Swedish longevity cluster suggests ecosystem-building around longevity science and advocacy.
Aging Can and Should be StoppedThe TEDx talk frames aging as a tractable and morally urgent target, expressing an advocacy-first strategy.
Portfolio

Investments

No public rows yet.

Donations

No public rows yet.

Organizations founded

Scientific output
h-index-
Citations-
Papers0
Trials0

No public rows yet.

Bravery and conviction